The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations.
Rivenbark
Ashley G
AG
Department of Pathology and Laboratory Medicine, Program in Translational Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine Chapel Hill, North Carolina 27599, USA.
Coleman
William B
WB
D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D019175:DNA Methylation; D004273:DNA, Neoplasm / Q000235:genetics; D044127:Epigenesis, Genetic; D016147:Genes, Tumor Suppressor; D005819:Genetic Markers; D014943:Global Health; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D012307:Risk Factors
D004273:DNA, Neoplasm; D005819:Genetic Markers